Clinical Trials in Georgia

Showing 13541-13560 of 19,050 trials

Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing

NCT01427296

The purpose of this study is to compare the safety and efficacy of OsmoPrep tablets versus HalfLytely and Bisacodyl Tablet Bowel Prep Kit in subjects who are undergoing colonoscopy.

Colon Cleansing

Bausch Health Americas, Inc.2,154 participantsStarted Sep 2011

San Carlos, California, United States • Bristol, Connecticut, United States • Macon, Georgia, United States +15 more locations

COMPLETEDPhase 314 miles

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

NCT01449929

This study will be conducted in approximately 468 HIV-1 infected antiretroviral therapy (ART)-naïve subjects. Subjects will be randomized 1:1 to receive dolutegravir (DTG) 50 mg once daily (approximately 234 subjects) or darunavir/ritonavir (DRV/r) 800 mg/100 mg once daily (approximately 234 subjects), each in combination with fixed-dose dual nucleoside reverse transriptase inhibitor (NRTI) therapy (either abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC). Subjects will be stratified by screening HIV-1 RNA and background NRTI selection. The primary analysis will take place after the last subject completes 48 weeks on therapy; an additional analysis will be conducted after the last subject completes Week 96 on study.

Infection, Human Immunodeficiency Virus

ViiV Healthcare488 participantsStarted Oct 2011

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +63 more locations

Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

Find Trials by Condition in Georgia

A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma

Structurally Reorganizing Motor Cortex in Stroke Patients Through Hebbian-type Stimulation

Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women

TR(ACE) Assay Clinical Specimen Study

Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes

The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

Alendronate to Prevent Loss of Bronchoprotection in Asthma

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients.

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis

3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study

Multi-site Validation and Application of a Consensus DSC-MRI Protocol